The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The NETFIT trial: Smart wearable medical devices to assess the quality of life of patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).
 
Javier Molina Cerrillomd
Consulting or Advisory Role - Advanced Accelerator Applications; Advanz Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; Pfizer
Research Funding - Ipsen; Janssen; Pfizer
 
Teresa Alonso-Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Lilly O.; Merck; Pfizer; Roche; Sanofi
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dr. Reddy's Laboratories; Eisai; Eusa Pharma; EUSA Pharma; GlaxoSmithKline; IPSEN; Janssen-Cilag; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Marta Benavent
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Maria-Isabel del Olmo
No Relationships to Disclose
 
Ana B. Custodio
No Relationships to Disclose
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Bayer; Eisai; Ipsen; Novartis; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Eisai; Ipsen; Novartis; Roche
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Amgen; AstraZeneca (I); Bayer; BMS; Boehringer Ingelheim; Esteve; Gilead Sciences (I); Hutchmed; Ipsen; Lilly (I); Merck; Midatech Pharma; Mirati Therapeutics (I); MSD; Novartis; Pfizer (I); PharmaMar; Roche (I); Sanofi (I); Servier; Takeda (I)
Consulting or Advisory Role - HMP
Research Funding - BMS (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Esteve; Ipsen; Merck; MSD
 
Alex Teule
Honoraria - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications
 
Vicente Alonso
Consulting or Advisory Role - Amgen; Ipsen; Merck Serono; Novartis; Pierre Fabre; Sanofi/Regeneron; SERVIER
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck Serono; Novartis; Sanofi; SERVIER
 
Eider Pascual-Corrales
No Relationships to Disclose
 
Marta Araujo-Castro
No Relationships to Disclose
 
Nieves Martinez Lago
No Relationships to Disclose
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer